Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 209-294-7 | CAS number: 565-80-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 973
- Report date:
- 1973
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Principles of method if other than guideline:
- A test group consisting of 5 animals/sex was treated by single gavage application with an aqueous solution of the test substance (6400, 5000, 4500, 4000, 3200 µL/kg via an emulsion containing 30 % test substance). The animals were observed for mortality and for clinical symptoms of toxicity. At the end of the observation period, the surviving animals were sacrificed for the purpose of necropsy; animals that died during the observation period also were subjected to necropsy.
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- 2,4-dimethylpentan-3-one
- EC Number:
- 209-294-7
- EC Name:
- 2,4-dimethylpentan-3-one
- Cas Number:
- 565-80-0
- Molecular formula:
- C7H14O
- IUPAC Name:
- 2,4-dimethylpentan-3-one
- Test material form:
- liquid
- Details on test material:
- - Name of test material (as cited in report): 2,4-Dimethylpentanon-3 / Diisopropyl keton
- Physical state: liquid
Constituent 1
- Specific details on test material used for the study:
- - Name of test material (as cited in report): 2,4-Dimethylpentanon-3 / Diisopropyl keton
- Physical state: liquid
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Remarks:
- Gassner
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation (mean): Males 216 g, females 179 g
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- CMC (carboxymethyl cellulose)
- Remarks:
- Aquatic emulsion with CMC and 2-3 drops Cremophor EL
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 30 % v/v
MAXIMUM DOSE VOLUME APPLIED: 6400 µL/kg
- Doses:
- 6400, 5000, 4500, 4000, 3200 µL/kg (Conc. 30 %)
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Necropsy of survivors performed: yes
Other examinations performed: clinical signs, body weight - Statistics:
- LD50 calculation according to LITCHFIELD und WILCOXON
Results and discussion
Effect levelsopen allclose all
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 3 645 mg/kg bw
- Based on:
- act. ingr.
- Remarks on result:
- other: based on a relative density of 0.81
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 4.5 mL/kg bw
- Based on:
- act. ingr.
- Mortality:
- At 6400 µL/kg bw: 4/5 male and 3/ female animals died within 1 hour after dosing. All male animals were dead within 7 days and all female animals within 48 hours.
At 5000 µL/kg bw: 1/5 male and 1/5 female animals died within 24 hours after dosing. All male animals and 4/5 female animals were dead within 7 days. The last surviving female animal died in the last week of observation (within 14 days).
At 4500 µL/kg bw: 1 male animal died within the 14 day observation period. 1/5 female animals died with 48 hours after dosing and 4/5 died within 7 days after dosing. The last surviving female animal died in the last week of observation (within 14 days).
4000 µl/kg bw: no mortality occurred
3200 µl/kg bw: no mortality occurred - Clinical signs:
- other: Immediately after application accelerated breathing was observed. Depending on the dosage, 1-40 minutes later tumbling, ragged breathing, crouching position, occasionally prone position and apathy was observed. After some hours apathy, irregular breathin
- Gross pathology:
- Animals which died of exposure:
6400 µL/kg bw: Acute dilatation of the heart. Dilation of the stomach (slight) containing thin pulpy contents or bloody ulcerations. Slight diarrhea contents in the intestines or hematised content of the intestines. Yellow gray discoloration of the liver, combined with dilation of the right atrium. General degeneration of the liver. Nephrosis
5000 µL/kg bw: Acute congestive hyperemia. Substance penetration through the stomach as well as Bloody ulcerations., Poor coagulation of the blood. Acute dilatation of the heart. Brightened liver and Toxic liver dystrophy, Toxic nephrosis of the liver (icm Yellow gray discoloration). Hematised content of the intestines. Partly infarctoid blood-fill, partly stain-faced with odematization of the lungs
4500 µL/kg bw: Acute dilatation of the heart. Yellow gray discoloration of the liver. Degeneration of the Kidneys. Total empty stomach-intestinal canal, distended filled with gas. Strong emaciation.
Animals which were necropsied after observation period.
4000 µL/kg bw: Total loss of perirenal adipose tissue. Edema of the for-stomach. Animals largely emaciated.
3200 µL/kg bw: no effects observed.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.